24
T. Sato et al. / Journal of Organometallic Chemistry 753 (2014) 20e26
CH6-Ar). 13C{1H} NMR (100.60 MHz, CDCl3):
137.0, 133.6, 133.2, 128.8, 125.6.
d
154.5, 148.3, 146.4,
4.5. Synthesis of Rh(I)e1,5-cyclooctadiene complexes
4-cycloocta-1,5-diene)[4-methyl-2-(2-
4.5.1. Chloro(
h
4.3.2. 1-(2-Nitrobenzenesulfonyl)imidazole (2b)
nitrobenzenesulfonyl)-1,2,4-triazol-3-ylidene]rhodium(I) (4a)
In a Schlenk flask (50 mL), NaH (360 mg, 15.0 mmol) was added
to a solution of imidazole (1b) (1.02 g, 15.0 mmol) in anhydrous
DMF (15 mL) at 0 ꢁC and stirred for 15 min at same temperature.
Next, 2-nitrobenzenesulfonyl chloride (3.32 g, 15.0 mmol) was
added to the reaction mixture and stirred at room temperature for
1 h. The resulting mixture was poured into ice water (150 mL) and
extracted with toluene (3 ꢂ 45 mL). The combined organic layer
was dried over anhydrous Na2SO4 and concentrated in vacuo. The
crude product was purified by recrystallization from EtOAc/hexane
to afford 2b as a colorless needle (779 mg, 3.08 mmol, 21%). The
characterization of 2b is described in the literature [10]. 1H NMR
In a Schlenk tube (10 mL), NaHMDS (1.09 M in THF, 0.525 mmol,
0.48 mL) was added to a mixture of 3a$HOTf (209 mg, 0.500 mmol)
and [RhCl(cod)]2 (123 mg, 0.250 mmol) in anhydrous THF (7 mL)
at ꢀ78 ꢁC. The reaction mixture was warmed to room temperature
slowly and stirred for 12 h. The resulting salt was filtered off, and
the filtrate was concentrated under reduced pressure. The resulting
crude product was purified by column chromatography (SiO2, first
eluted with CH2Cl2 to remove the impurities followed by CH2Cl2/
acetone
¼
15/1) to afford 4a as a red powder (45.1 mg,
0.0876 mmol, 18%). The single crystals suitable for X-ray diffraction
analysis were obtained by the slow diffusion of hexane to the
(400.03 MHz, CDCl3):
d
(s, NCHN), 8.12 (dd, 1H, 3J ¼ 7.9 Hz,
acetone solution of 4a. 1H NMR (400.03 MHz, CDCl3):
d
8.95e8.87
4J ¼ 1.5 Hz, CH3-Ar), 7.89 (td, 1H, 3J ¼ 7.3 Hz, 4J ¼ 1.5 Hz, CH5-Ar),
7.86e7.79 (m, 2H, CH4-Ar, CH6-Ar), 7.43 (t, 1H, 3J ¼ 1.6 Hz, 4J ¼ 1.6 Hz,
NCHCHN), 7.15 (dd, 1H, 3J ¼ 1.6 Hz, 4J ¼ 0.8 Hz, NCHCHN). 13C{1H}
(m, 1H, CH3-Ar), 8.08 (s, 1H, NCHN), 7.95e7.81 (m, 3H, CH4-Ar, CH5-Ar
,
CH6-Ar), 5.12e4.98 (m,1H, CHCOD), 4.88e4.76 (m, 1H, CHCOD), 4.31 (s,
3H, CH3), 3.96e3.85 (m, 1H, CHCOD), 3.53e3.41 (m, 1H, CHCOD),
2.68e2.40 (m, 3H, CH2COD), 2.36e2.20 (m, 1H, CH2COD), 2.17e2.05
(m, 2H, CH2COD), 2.04e1.84 (m, 2H, CH2COD). 13C{1H} NMR
NMR (100.60 MHz, CDCl3):
131.0, 125.4, 118.2.
d 148.2, 137.6, 136.3, 133.1, 131.4, 131.1,
(100.60 MHz, CDCl3):
d
197.7 (d, 1JRhC ¼ 51.4 Hz, NCN), 148.5, 143.2,
4.4. Synthesis of azolium salts
136.8, 134.0, 132.6, 130.1, 125.8, 101.3 (d, 1JRhC ¼ 7.4 Hz, CHCOD), 100.1
(d, 1JRhC ¼ 6.8 Hz, CHCOD), 71.2 (d, 1JRhC ¼ 14.3 Hz, CHCOD), 71.1 (d,
1JRhC ¼ 13.6 Hz, CHCOD), 37.1, 33.8, 31.9, 29.5, 28.2. IR (KBr): 3067,
2927, 2830, 1543, 1467, 1396, 1360, 1198 cmꢀ1. HRMS (FAB):
[M ꢀ Cl]þ calcd for C17H20N4O4RhS 479.0260; found 479.0255. Anal.
Calcd (%) for C17H20ClN4O4RhS: C 39.66, H 3.92, N 10.88. Found: C
39.42, H 4.07, N 10.74. Mp. 155 ꢁC (dec).
4.4.1. 4-Methyl-1-(2-nitrobenzenesulfonyl)-1,2,4-triazol-4-ium
triflate (3a$HOTf)
In a Schlenk flask (20 mL), MeOTf (197 mg, 1.2 mmol) was added
to
a solution of 1-[(2-nitrobenzene)sulfonyl]imidazole (2a)
(305 mg, 1.20 mmol) in anhydrous CH2Cl2 (15 mL), and the reaction
mixture was stirred at room temperature for 4 h. Next, diethyl ether
(2 mL) was added to the reaction mixture, and the resulting pre-
cipitate was collected and purified by washing with diethyl ether
(2 ꢂ 5 mL). The solid was dried under vacuum to afford 3a$HOTf as
a white powder (479 mg, 1.15 mmol, 58%). 1H NMR (400.03 MHz,
4.5.2. Chloro(h
4-cycloocta-1,5-diene)[1-methyl-3-(2-
nitrobenzenesulfonyl)imidazol-2-ylidene]rhodium(I) (4b)
In a Schlenk tube (10 mL), NaHMDS (1.09 M in THF, 0.315 mmol,
0.29 mL) was added to a mixture of 3b$HOTf (125 mg, 0.300 mmol)
and [RhCl(cod)]2 (74.0 mg, 0.150 mmol) in anhydrous THF (5 mL)
at ꢀ78 ꢁC. The reaction mixture was warmed to room temperature
slowly and stirred for 12 h. The resulting salt was filtered off, and the
filtrate was concentrated under reduced pressure. The resulting
crude product was purified by column chromatography (SiO2, first
eluted with CH2Cl2 to remove the impurities followed by CH2Cl2/
acetone ¼ 15/1) to afford 4b as a red powder (107 mg, 0.208 mmol,
69%). The single crystals suitable for X-ray diffraction analysis were
obtained by the slow diffusion of hexane in an acetone solution of
acetone-d6):
d 10.94 (s, 1H, ArSO2NCHN), 9.42 (s, 1H, NCHNCH3),
8.63 (dd, 1H, 3J ¼ 7.9 Hz, 4J ¼ 1.3 Hz, CH3-Ar), 8.35 (ddd, 1H,
3J ¼ 8.0 Hz, 3J ¼ 7.2 Hz, 4J ¼ 1.3 Hz, CH5-Ar), 8.32 (dd, 1H, 3J ¼ 8.0 Hz,
4J ¼ 1.8 Hz, CH6-Ar), 8.23 (ddd, 1H, 3J ¼ 7.9 Hz, 3J ¼ 7.2 Hz, 4J ¼ 1.8 Hz,
CH4-Ar), 4.36 (s, 3H, CH3). 13C{1H} NMR (100.60 MHz, DMSO-d6):
d
149.2, 148.6, 148.0, 140.6, 138.8, 135.3, 135.3, 127.6, 126.4, 122.1 (q,
1JCF ¼ 320.7 Hz, CF3SO3), 36.3. 19F{1H} NMR (376.37 MHz, DMSO-
d6):
d
ꢀ77.27 (CF3SO3). IR (KBr): 3140, 3106, 1589, 1543, 1355, 1284,
1033 cmꢀ1. HRMS (FAB): [M ꢀ CF3SO3]þ calcd for C9H9N4O4S
269.0345; found 269.0344. Mp: 108 ꢁC.
4b. 1H NMR (400.03 MHz, CDCl3):
d
9.33 (dd, 1H, 3J ¼ 7.8 Hz,
4J ¼ 1.3 Hz, CH3-Ar), 7.96e7.88 (m, 3H, CH4-Ar, CH5-Ar, CH6-Ar), 7.65 (d,
1H, 3J ¼ 2.2 Hz, ArSO2NCHCHNCH3), 6.95 (d, 1H, 3J ¼ 2.2 Hz,
ArSO2NCHCHNCH3), 4.96e4.85 (m, 1H, CHCOD), 4.67e4.56 (m, 1H,
CHCOD), 4.28 (s, 3H, CH3), 4.04e3.91 (m, 1H, CHCOD), 3.57e3.45 (m,
1H, CHCOD), 2.68e2.42 (m, 3H, CH2COD), 2.30e2.16 (m, 1H, CH2COD),
2.16e2.02 (m, 2H, CH2COD), 2.00e1.85 (m, 1H, CH2COD), 1.85e1.72 (m,
4.4.2. 1-Methyl-3-(2-nitrobenzenesulfonyl)imidazol-1-ium triflate
(3b$HOTf)
In a Schlenk flask (20 mL), MeOTf (197 mg, 1.2 mmol) was added
to a solution of 1-[(2-nitrobenzene)sulfonyl]imidazole (2b) (304 mg,
1.20 mmol) in anhydrous CH2Cl2 (10 mL), and the reaction mixture
was stirred at room temperature for 30 min. Next, diethyl ether
(2 mL) was added to the reaction mixture, and the resulting pre-
cipitate was collected and purified by washing with diethyl ether
(2 ꢂ 5 mL). The solid was dried under vacuum to afford 3b$HOTf as a
1H, CH2COD). 13C{1H} NMR (100.60 MHz, CDCl3):
d 189.7 (d,
1JRhC ¼ 51.3 Hz, NCN), 148.1, 136.8, 135.0, 132.4, 130.6, 126.1, 122.9,
121.7, 99.7 (d, 1JRhC ¼ 7.6 Hz, CHCOD), 97.8 (d, 1JRhC ¼ 7.4 Hz, CHCOD),
71.7 (d, 1JRhC ¼ 14.4 Hz, CHCOD), 69.6 (d, 1JRhC ¼ 14.0 Hz, CHCOD), 39.8,
34.0, 31.8, 29.8, 27.8. IR (KBr): 3175, 3109, 2945, 1592, 1381, 1238,
1183, 1150, 1085 cmꢀ1. HRMS (FAB): [M]þ calcd for C18H21ClN3O4RhS
512.9996; found 512.9990. Anal. Calcd (%) for C18H21ClN3O4RhS: C
42.08, H 4.12, N 8.18. Found: C 41.89, H 4.01, N 8.02. Mp. 163 ꢁC (dec).
1
white powder (356 mg, 0.853 mmol, 71%). H NMR (400.03 MHz,
DMSO-d6):
d
9.05 (s, 1H, NCHN), 7.84 (dd, 1H, 3J ¼ 7.8 Hz, 4J ¼ 1.5 Hz,
CH3-Ar), 7.70 (t, 1H, 3J ¼ 1.6 Hz, 4J ¼ 1.6 Hz, NCHCHN), 7.67 (t, 1H,
3J ¼ 1.6 Hz, 4J ¼ 1.6 Hz, NCHCHN), 7.58 (td,1H, 3J ¼ 7.8 Hz, 4J ¼ 1.5 Hz,
CH5-Ar), 7.57 (dd, 1H, 3J ¼ 7.8 Hz, 4J ¼ 1.5 Hz, CH6-Ar), 7.51 (td, 1H,
3J ¼ 7.8 Hz, 4J ¼ 1.5 Hz, CH4-Ar), 3.86 (s, 3H, CH3). 13C{1H} NMR
4.6. Synthesis of Rh(I)ecarbonyl complexes
(100.60 MHz, DMSO-d6):
d 147.8, 139.3, 135.8, 130.8, 130.1, 129.0,
123.2, 122.4, 120.4 (q, JCF ¼ 321.1 Hz, CF3SO3), 119.8, 36.3. 19F{1H}
4.6.1. Chlorodicarbonyl[4-methyl-2-(2-nitrobenzenesulfonyl)-1,2,4-
triazol-3-ylidene]rhodium(I) (5a)
CO gas was bubbled through a solution of 4a (25.7 mg,
0.0500 mmol) in anhydrous CH2Cl2 (2 mL) for the IR or in CDCl3
1
NMR (376.37 MHz, DMSO-d6):
d
ꢀ77.26 (CF3SO3). IR (KBr): 3163,
3085,1594,1549,1413,1260 cmꢀ1. HRMS (FAB): [M ꢀ CF3SO3]þ calcd
for C10H10N3O4S 268.0392; found 268.0394. Mp: 94 ꢁC.